Skip to content
PoliticalRepoPoliticalRepo

United States · Bill · HR

H.R. 3059 (112th)

Creating Hope Act of 2011

referredUnited States· United States Congress· EN

Introduced

23 September 2011

Last action

26 September 2011 · Referred

Status

Referred to the Subcommittee on Health.

Sponsors

Rep. McCaul, Michael T. [R-TX-10], Rep. Butterfield, G. K. [D-NC-1], Rep. Myrick, Sue Wilkins [R-NC-9], Sen. Van Hollen, Chris [D-MD], Rep. Burgess, Michael C. [R-TX-26], Rep. Speier, Jackie [D-CA-14], Rep. Kelly, Mike [R-PA-16], Rep. Johnson, Henry C. "Hank" [D-GA-4], Rep. Davis, Danny K. [D-IL-7], Rep. Towns, Edolphus [D-NY-10], Del. Christensen, Donna M. [D-VI-At Large], Rep. Rush, Bobby L. [D-IL-1], Rep. Cuellar, Henry [D-TX-28], Rep. Bilbray, Brian P. [R-CA-50], Rep. Wolf, Frank R. [R-VA-10], Rep. McMorris Rodgers, Cathy [R-WA-5], Rep. Keating, William R. [D-MA-9], Rep. Olson, Pete [R-TX-22], Rep. Canseco, Francisco "Quico" [R-TX-23], Rep. Rogers, Mike D. [R-AL-3], Rep. Boustany, Charles W., Jr. [R-LA-3], Rep. Davis, Geoff [R-KY-4], Rep. Ros-Lehtinen, Ileana [R-FL-27], Rep. Pelosi, Nancy [D-CA-11], Rep. Rothman, Steven R. [D-NJ-9], Rep. Castor, Kathy [D-FL-14], Rep. Connolly, Gerald E. [D-VA-11], Sen. Blackburn, Marsha [R-TN], Rep. Bachus, Spencer [R-AL-6], Rep. Roby, Martha [R-AL-2], Rep. Carter, John R. [R-TX-31], Rep. King, Peter T. [R-NY-2], Rep. Paul, Ron [R-TX-14], Sen. Markey, Edward J. [D-MA], Rep. Moran, James P. [D-VA-8], Sen. Lankford, James [R-OK], Rep. Luetkemeyer, Blaine [R-MO-3], Rep. Jackson Lee, Sheila [D-TX-18], Rep. Rangel, Charles B. [D-NY-15], Rep. Carnahan, Russ [D-MO-3], Rep. Schmidt, Jean [R-OH-2], Rep. Gallegly, Elton [R-CA-24], Rep. Roskam, Peter J. [R-IL-6], Rep. Jones, Walter B., Jr. [R-NC-3], Rep. Filner, Bob [D-CA-51], Rep. DeGette, Diana [D-CO-1], Rep. Doyle, Michael F. [D-PA-14], Rep. Tiberi, Patrick J. [R-OH-12]

Subjects

Healthcare

Source updated

10 January 2026

Healthcare

Summary

Creating Hope Act of 2011 - Amends the Federal Food, Drug, and Cosmetic Act to revise the priority review voucher program for tropical diseases to: (1) include rare pediatric diseases; (2) allow unlimited transfers of vouchers under the program; and (3) require a sponsor intending to use a voucher to notify the Secretary of Health and Human Services (HHS) at least 90 days (currently, 365 days) before submission of the application. Revises provisions regarding the priority review user fee, including to make it payable upon notification of the Secretary of intent to use the voucher. Authorizes the Secretary, upon request of the manufacturer or sponsor of a new drug, to designate that a new drug is: (1) for a rare pediatric disease, and (2) an eligible treatment. Requires the Secretary to deem a rare pediatric disease product application to be incomplete if it does not contain a description of the sponsor's plan to market the product in the United States. Authorizes the Secretary to refuse to issue a priority review voucher upon the approval of a rare pediatric disease application if the Secretary finds that the sponsor lacks a good faith intention to market the product in the United States. Directs the Secretary to issue a guidance document setting forth the evidentiary support necessary to demonstrate such a good faith intention. Requires sponsors of applications under the priority review voucher program to report to the Secretary within five years after the approval of the application on the demand and distribution of the product within the United States.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 23 September 2011

    Introduced

    Referred to the House Committee on Energy and Commerce.

    Source: IntroReferral

  2. 23 September 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 23 September 2011

    Introduced

    Introduced in House

    Source: IntroReferral

  4. 26 September 2011

    Referred

    Referred to the Subcommittee on Health.

    Source: Committee

Votes

No vote records are attached yet.

Versions

Documents

3 official files

Introduced in House (text)

View fileDownload file

This file cannot be previewed here. Use View or Download.

Leesvertaling

Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House (text)

    Introduced in House · EN · 23 September 2011

    ViewDownloadOpen at official source

  • Introduced in House (PDF)

    Introduced in House · EN · 23 September 2011

    ViewDownloadOpen at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

  • Introduced in House

    summary · EN · 23 September 2011

    Open at official source

    Leesvertaling

    Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.

    Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.

Sponsors

Showing 48 of 175 sponsors and actors.

Related records

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.